Francois Goldwasser

Author PubWeight™ 15.22^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.	J Clin Oncol	2011	6.16
2	Controlling tumor growth by modulating endogenous production of reactive oxygen species.	Cancer Res	2005	3.12
3	Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.	Pharm Res	2011	0.96
4	A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasma.	J Chromatogr B Analyt Technol Biomed Life Sci	2011	0.90
5	Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma.	Invest New Drugs	2010	0.85
6	An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients.	J Chromatogr B Analyt Technol Biomed Life Sci	2013	0.81
7	Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancer.	Nutr Cancer	2013	0.78
8	Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.	Expert Opin Drug Saf	2014	0.76
9	An original administration of ifosfamide given once every other week: a clinical and pharmacological study.	Anticancer Drugs	2008	0.76
10	Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.	Expert Opin Investig Drugs	2015	0.76